A detailed history of Raymond James Trust N.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Raymond James Trust N.A. holds 21,388 shares of BSX stock, worth $1.79 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
21,388
Previous 17,064 25.34%
Holding current value
$1.79 Million
Previous $1.17 Million 41.01%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$67.33 - $77.71 $291,134 - $336,018
4,324 Added 25.34%
21,388 $1.65 Million
Q1 2024

Apr 24, 2024

BUY
$57.6 - $68.62 $5,529 - $6,587
96 Added 0.57%
17,064 $1.17 Million
Q4 2023

Jan 10, 2024

BUY
$48.64 - $57.81 $57,735 - $68,620
1,187 Added 7.52%
16,968 $980,000
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $102,789 - $111,984
2,048 Added 14.91%
15,781 $833,000
Q2 2023

Aug 15, 2023

BUY
$49.72 - $54.64 $111,571 - $122,612
2,244 Added 19.53%
13,733 $743,000
Q1 2023

May 03, 2023

BUY
$45.09 - $50.03 $15,736 - $17,460
349 Added 3.13%
11,489 $575,000
Q4 2022

Feb 02, 2023

SELL
$39.56 - $47.22 $29,749 - $35,509
-752 Reduced 6.32%
11,140 $516,000
Q3 2022

Oct 31, 2022

SELL
$36.71 - $109.66 $92,031 - $274,917
-2,507 Reduced 17.41%
11,892 $461,000
Q2 2022

Jul 14, 2022

BUY
$35.24 - $47.1 $10,325 - $13,800
293 Added 2.08%
14,399 $536,000
Q1 2022

May 12, 2022

SELL
$40.9 - $45.1 $175,297 - $193,298
-4,286 Reduced 23.3%
14,106 $625,000
Q4 2021

Jan 31, 2022

SELL
$38.07 - $44.87 $61,977 - $73,048
-1,628 Reduced 8.13%
18,392 $781,000
Q3 2021

Oct 18, 2021

BUY
$41.23 - $45.88 $412 - $458
10 Added 0.05%
20,020 $868,000
Q2 2021

Jul 20, 2021

BUY
$38.58 - $44.24 $169,752 - $194,656
4,400 Added 28.19%
20,010 $856,000
Q1 2021

May 03, 2021

BUY
$35.27 - $39.67 $105,704 - $118,890
2,997 Added 23.76%
15,610 $603,000
Q4 2020

Jan 13, 2021

BUY
$33.15 - $41.97 $32,122 - $40,668
969 Added 8.32%
12,613 $453,000
Q3 2020

Oct 14, 2020

SELL
$34.44 - $42.23 $3,650 - $4,476
-106 Reduced 0.9%
11,644 $445,000
Q2 2020

Jul 16, 2020

BUY
$30.19 - $39.11 $9,358 - $12,124
310 Added 2.71%
11,750 $412,000
Q1 2020

Apr 17, 2020

SELL
$25.83 - $45.71 $7,542 - $13,347
-292 Reduced 2.49%
11,440 $373,000
Q4 2019

Jan 14, 2020

BUY
$37.87 - $45.37 $53,586 - $64,198
1,415 Added 13.72%
11,732 $530,000
Q3 2019

Oct 24, 2019

BUY
$40.31 - $43.45 $146,083 - $157,462
3,624 Added 54.15%
10,317 $420,000
Q2 2019

Jul 15, 2019

BUY
$34.91 - $42.98 $12,672 - $15,601
363 Added 5.73%
6,693 $287,000
Q1 2019

Apr 15, 2019

SELL
$32.91 - $40.75 $27,644 - $34,230
-840 Reduced 11.72%
6,330 $243,000
Q4 2018

Jan 29, 2019

BUY
$31.73 - $39.04 $27,478 - $33,808
866 Added 13.74%
7,170 $253,000
Q3 2018

Oct 16, 2018

BUY
$32.83 - $38.63 $206,960 - $243,523
6,304 New
6,304 $243,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.